Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRT62
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,796
Award facts
- Contract value 100% obligated
- $11,796.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections, with a ceiling value of $11,796.25 and an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to the federal government, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a wide range of medications, vaccines, and medical devices to support military healthcare programs globally. Zepbound, a diabetes medication, aligns with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied through the DLA, which includes specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FRT62?
SPE2DB25FRT62 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FRT62 worth?
The government has obligated $11,796 on SPE2DB25FRT62.
Is contract SPE2DB25FRT62 an order under another contract?
Yes. SPE2DB25FRT62 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRT62 competed?
The extent of competition for SPE2DB25FRT62 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award